Fam72a enforces error-prone DNA repair during antibody diversification.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
12 2021
Historique:
received: 17 12 2020
accepted: 04 10 2021
pubmed: 26 11 2021
medline: 1 3 2022
entrez: 25 11 2021
Statut: ppublish

Résumé

Efficient humoral responses rely on DNA damage, mutagenesis and error-prone DNA repair. Diversification of B cell receptors through somatic hypermutation and class-switch recombination are initiated by cytidine deamination in DNA mediated by activation-induced cytidine deaminase (AID)

Identifiants

pubmed: 34819671
doi: 10.1038/s41586-021-04093-y
pii: 10.1038/s41586-021-04093-y
doi:

Substances chimiques

Ung protein, mouse EC 3.2.2
Uracil 56HH86ZVCT
Fam72a protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

329-333

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Feng, Y., Seija, N., Di Noia, J. M. & Martin, A. AID in antibody diversification: there and back again. Trends Immunol. 41, 586–600 (2020).
doi: 10.1016/j.it.2020.04.009
Methot, S. P. & Di Noia, J. M. Molecular mechanisms of somatic hypermutation and class switch recombination. Adv. Immunol. 133, 37–87 (2017).
doi: 10.1016/bs.ai.2016.11.002
Stratigopoulou, M., van Dam, T. P. & Guikema, J. E. J. Base excision repair in the immune system: small DNA lesions with big consequences. Front. Immunol. 11, 1084 (2020).
doi: 10.3389/fimmu.2020.01084
Krokan, H. E. et al. Error-free versus mutagenic processing of genomic uracil—relevance to cancer. DNA Repair 19, 38–47 (2014).
doi: 10.1016/j.dnarep.2014.03.028
Guo, C. et al. Ugene, a newly identified protein that is commonly overexpressed in cancer and binds uracil DNA glycosylase. Cancer Res. 68, 6118–6126 (2008).
doi: 10.1158/0008-5472.CAN-08-1259
Rada, C. et al. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12, 1748–1755 (2002).
doi: 10.1016/S0960-9822(02)01215-0
Zanotti, K. J. & Gearhart, P. J. Antibody diversification caused by disrupted mismatch repair and promiscuous DNA polymerases. DNA Repair 38, 110–116 (2016).
doi: 10.1016/j.dnarep.2015.11.011
Nakamura, M. et al. High frequency class switching of an IgM
doi: 10.1093/intimm/8.2.193
Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR–Cas9. Nat. Biotechnol. 34, 184–191 (2016).
doi: 10.1038/nbt.3437
Joung, J. et al. Genome-scale CRISPR–Cas9 knockout and transcriptional activation screening. Nat. Protoc. 12, 828–863 (2017).
doi: 10.1038/nprot.2017.016
KOMP strain detail sheet. MMRRC < https://www.mmrrc.org/catalog/sds.php?mmrrc_id=47653 >
Sarno, A. et al. Uracil-DNA glycosylase UNG1 isoform variant supports class switch recombination and repairs nuclear genomic uracil. Nucleic Acids Res. 47, 4569–4585 (2019).
doi: 10.1093/nar/gkz145
Begum, N. A. et al. Uracil DNA glycosylase activity is dispensable for immunoglobulin class switch. Science 305, 1160-1163 (2004).
doi: 10.1126/science.1098444
Di Noia, J. M. et al. Dependence of antibody gene diversification on uracil excision. J. Exp. Med. 204, 3209-3219 (2007).
doi: 10.1084/jem.20071768
Yousif, A. S., Stanlie, A., Mondal, S., Honjo, T. & Begum, N. A. Differential regulation of S-region hypermutation and class-switch recombination by noncanonical functions of uracil DNA glycosylase. Proc. Natl Acad. Sci. USA 111, E1016-E1024 (2014).
doi: 10.1073/pnas.1402391111
Eldin, P. et al. Impact of HIV-1 Vpr manipulation of the DNA repair enzyme UNG2 on B lymphocyte class switch recombination. J. Transl. Med. 18, 310 (2020).
doi: 10.1186/s12967-020-02478-7
Holland, A. J., Fachinetti, D., Han, J. S. & Cleveland, D. W. Inducible, reversible system for the rapid and complete degradation of proteins in mammalian cells. Proc. Natl Acad. Sci. USA 109, E3350-E3357 (2012).
doi: 10.1073/pnas.1216880109
Arakawa, H., Saribasak, H. & Buerstedde, J. M. Activation-induced cytidine deaminase initiates immunoglobulin gene conversion and hypermutation by a common intermediate. PLoS Biol. 2, E179 (2004).
doi: 10.1371/journal.pbio.0020179
Martin, O. A. et al. Detecting rare AID-induced mutations in B-lineage oncogenes from high-throughput sequencing data using the detection of minor variants by error correction method. J. Immunol. 201, 950–956 (2018).
doi: 10.4049/jimmunol.1800203
Dev, H. et al. Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells. Nat. Cell Biol. 20, 954–965 (2018).
doi: 10.1038/s41556-018-0140-1
Yan, C. T. et al. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 449, 478–482 (2007).
doi: 10.1038/nature06020
Krokan, H. E. & Bjoras, M. Base excision repair. Cold Spring Harb. Perspect. Biol. 5, a012583 (2013).
doi: 10.1101/cshperspect.a012583
Krokan, H. E., Drablos, F. & Slupphaug, G. Uracil in DNA—occurrence, consequences and repair. Oncogene 21, 8935–8948 (2002).
doi: 10.1038/sj.onc.1205996
Wu, X. & Stavnezer, J. DNA polymerase beta is able to repair breaks in switch regions and plays an inhibitory role during immunoglobulin class switch recombination. J. Exp. Med. 204, 1677–1689 (2007).
doi: 10.1084/jem.20070756
Schrader, C. E., Guikema, J. E., Wu, X. & Stavnezer, J. The roles of APE1, APE2, DNA polymerase β and mismatch repair in creating S region DNA breaks during antibody class switch. Phil. Trans. R. Soc. B 364, 645–652 (2009).
doi: 10.1098/rstb.2008.0200
Nilsen, H. et al. Gene-targeted mice lacking the Ung uracil-DNA glycosylase develop B-cell lymphomas. Oncogene 22, 5381–5386 (2003).
doi: 10.1038/sj.onc.1206860
Andersen, S. et al. Monoclonal B-cell hyperplasia and leukocyte imbalance precede development of B-cell malignancies in uracil-DNA glycosylase deficient mice. DNA Repair 4, 1432–1441 (2005).
doi: 10.1016/j.dnarep.2005.08.004
Nilsen, H., An, Q. & Lindahl, T. Mutation frequencies and AID activation state in B-cell lymphomas from Ung-deficient mice. Oncogene 24, 3063–3066 (2005).
doi: 10.1038/sj.onc.1208480
Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol. 15, 554 (2014).
doi: 10.1186/s13059-014-0554-4
Kleinstiver, B. P. et al. High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529, 490–495 (2016).
doi: 10.1038/nature16526
Miyazaki, K. MEGAWHOP cloning: a method of creating random mutagenesis libraries via megaprimer PCR of whole plasmids. Methods Enzymol. 498, 399–406 (2011).
doi: 10.1016/B978-0-12-385120-8.00017-6
Maccarthy, T., Roa, S., Scharff, M. D. & Bergman, A. SHMTool: a webserver for comparative analysis of somatic hypermutation datasets. DNA Repair 8, 137–141 (2009).
doi: 10.1016/j.dnarep.2008.09.006
Engler, C., Gruetzner, R., Kandzia, R. & Marillonnet, S. Golden gate shuffling: a one-pot DNA shuffling method based on type IIs restriction enzymes. PLoS ONE 4, e5553 (2009).
doi: 10.1371/journal.pone.0005553
Motohashi, K. A simple and efficient seamless DNA cloning method using SLiCE from Escherichia coli laboratory strains and its application to SLiP site-directed mutagenesis. BMC Biotechnol. 15, 47 (2015).
doi: 10.1186/s12896-015-0162-8
Lescale, C. et al. RAG2 and XLF/Cernunnos interplay reveals a novel role for the RAG complex in DNA repair. Nat. Commun. 7, 10529 (2016).
doi: 10.1038/ncomms10529
Jeevan-Raj, B. P. et al. Epigenetic tethering of AID to the donor switch region during immunoglobulin class switch recombination. J. Exp. Med. 208, 1649–1660 (2011).
doi: 10.1084/jem.20110118
Holden, P. & Horton, W. A. Crude subcellular fractionation of cultured mammalian cell lines. BMC Res. Notes 2, 243 (2009).
doi: 10.1186/1756-0500-2-243

Auteurs

Mélanie Rogier (M)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France.
Institut National de la Santé et de la Recherche Médicale (INSERM), U1258, Illkirch, France.
Centre National de la Recherche Scientifique (CNRS), UMR7104, Illkirch, France.
Université de Strasbourg, Illkirch, France.

Jacques Moritz (J)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France.
Institut National de la Santé et de la Recherche Médicale (INSERM), U1258, Illkirch, France.
Centre National de la Recherche Scientifique (CNRS), UMR7104, Illkirch, France.
Université de Strasbourg, Illkirch, France.

Isabelle Robert (I)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France.
Institut National de la Santé et de la Recherche Médicale (INSERM), U1258, Illkirch, France.
Centre National de la Recherche Scientifique (CNRS), UMR7104, Illkirch, France.
Université de Strasbourg, Illkirch, France.

Chloé Lescale (C)

Genome Integrity, Immunity and Cancer Unit, Equipe Labellisée Ligue Contre Le Cancer, INSERM U1223, Institut Pasteur, Paris, France.

Vincent Heyer (V)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France.
Institut National de la Santé et de la Recherche Médicale (INSERM), U1258, Illkirch, France.
Centre National de la Recherche Scientifique (CNRS), UMR7104, Illkirch, France.
Université de Strasbourg, Illkirch, France.

Arthur Abello (A)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France.
Institut National de la Santé et de la Recherche Médicale (INSERM), U1258, Illkirch, France.
Centre National de la Recherche Scientifique (CNRS), UMR7104, Illkirch, France.
Université de Strasbourg, Illkirch, France.

Ophélie Martin (O)

Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK.

Katia Capitani (K)

Core Research Laboratory, ISPRO, Firenze, Italy.
Department of Medical Biotechnologies, University of Siena, Siena, Italy.

Morgane Thomas (M)

Centre National de la Recherche Scientifique (CNRS), UMR7276, Institut National de la Santé et de la Recherche Médicale (INSERM), UMR1262-Contrôle de la Réponse Immune B et Lymphoproliférations, Université de Limoges, Limoges, France.

Anne-Sophie Thomas-Claudepierre (AS)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France.
Institut National de la Santé et de la Recherche Médicale (INSERM), U1258, Illkirch, France.
Centre National de la Recherche Scientifique (CNRS), UMR7104, Illkirch, France.
Université de Strasbourg, Illkirch, France.

Brice Laffleur (B)

Institut national de la santé et de la recherche médicale (INSERM), UMR1236, Université Rennes 1, Etablissement Français du Sang Bretagne, Rennes, France.

Florence Jouan (F)

Institut national de la santé et de la recherche médicale (INSERM), UMR1236, Université Rennes 1, Etablissement Français du Sang Bretagne, Rennes, France.

Eric Pinaud (E)

Centre National de la Recherche Scientifique (CNRS), UMR7276, Institut National de la Santé et de la Recherche Médicale (INSERM), UMR1262-Contrôle de la Réponse Immune B et Lymphoproliférations, Université de Limoges, Limoges, France.

Karin Tarte (K)

Institut national de la santé et de la recherche médicale (INSERM), UMR1236, Université Rennes 1, Etablissement Français du Sang Bretagne, Rennes, France.

Michel Cogné (M)

Centre National de la Recherche Scientifique (CNRS), UMR7276, Institut National de la Santé et de la Recherche Médicale (INSERM), UMR1262-Contrôle de la Réponse Immune B et Lymphoproliférations, Université de Limoges, Limoges, France.
Institut national de la santé et de la recherche médicale (INSERM), UMR1236, Université Rennes 1, Etablissement Français du Sang Bretagne, Rennes, France.

Silvestro G Conticello (SG)

Core Research Laboratory, ISPRO, Firenze, Italy.
Institute of Clinical Physiology, National Research Council, Pisa, Italy.

Evi Soutoglou (E)

Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK.

Ludovic Deriano (L)

Genome Integrity, Immunity and Cancer Unit, Equipe Labellisée Ligue Contre Le Cancer, INSERM U1223, Institut Pasteur, Paris, France.

Bernardo Reina-San-Martin (B)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France. reinab@igbmc.fr.
Institut National de la Santé et de la Recherche Médicale (INSERM), U1258, Illkirch, France. reinab@igbmc.fr.
Centre National de la Recherche Scientifique (CNRS), UMR7104, Illkirch, France. reinab@igbmc.fr.
Université de Strasbourg, Illkirch, France. reinab@igbmc.fr.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH